{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:20:29Z","timestamp":1791901229329,"version":"4.3.4"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10741-013-9377-8","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T07:19:10Z","timestamp":1361863150000},"page":"35-48","source":"Crossref","is-referenced-by-count":119,"title":["Metabolic dysfunction in diabetic cardiomyopathy"],"prefix":"10.1007","volume":"19","author":[{"given":"Michael","family":"Isfort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C. W.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chian Ju","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren E.","family":"Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"9377_CR1","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association. Circulation 125:e2\u2013e220","journal-title":"Circulation"},{"key":"9377_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(10)62346-X","volume":"377","author":"SS Anand","year":"2011","unstructured":"Anand SS, Yusuf S (2011) Stemming the global tsunami of cardiovascular disease. Lancet 377:529\u2013532","journal-title":"Lancet"},{"key":"9377_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm0106-62","volume":"12","author":"D Yach","year":"2006","unstructured":"Yach D, Stuckler D, Brownell KD (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62\u201366","journal-title":"Nat Med"},{"key":"9377_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2006.08.018","volume":"42","author":"CH Shao","year":"2007","unstructured":"Shao CH, Rozanski GJ, Patel KP et al (2007) Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats. J Mol Cell Cardiol 42:234\u2013246","journal-title":"J Mol Cell Cardiol"},{"key":"9377_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diabetes.55.03.06.db05-1284","volume":"55","author":"L Pereira","year":"2006","unstructured":"Pereira L, Matthes J, Schuster I et al (2006) Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db\/db type 2 diabetic mice. Diabetes 55:608\u2013615","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"9377_CR6","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0168-8227(11)70008-0","volume":"93","author":"SA Schafer","year":"2011","unstructured":"Schafer SA, Machicao F, Fritsche A et al (2011) New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res Clin Pract 93(Suppl 1):S9\u2013S24","journal-title":"Diabetes Res Clin Pract"},{"key":"9377_CR7","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","volume":"291","author":"D An","year":"2006","unstructured":"An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489\u2013H1506","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR8","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213\u20133223","journal-title":"Circulation"},{"key":"9377_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20100501","volume":"121","author":"DP Barlovic","year":"2011","unstructured":"Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA (2011) RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 121:43\u201355","journal-title":"Clin Sci (Lond)"},{"key":"9377_CR10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamcr.2011.01.014","volume":"1813","author":"JG Duncan","year":"2011","unstructured":"Duncan JG (2011) Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 1813:1351\u20131359","journal-title":"Biochim Biophys Acta"},{"key":"9377_CR11","volume-title":"Atlanta","author":"Department of Health and Human Services CfDCaP","year":"2011","unstructured":"Department of Health and Human Services CfDCaP (2011) Atlanta. GA. National Diabetes Fact Sheet, National Estimates and General Information on Diabetes and Prediabetes in the United States"},{"key":"9377_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","volume":"23","author":"MJ Garcia","year":"1974","unstructured":"Garcia MJ, McNamara PM, Gordon T et al (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105\u2013111","journal-title":"Diabetes"},{"key":"9377_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1385\/ENDO:25:2:073","volume":"25","author":"J Ren","year":"2004","unstructured":"Ren J, Ceylan-Isik AF (2004) Diabetic cardiomyopathy: do women differ from men? Endocrine 25:73\u201383","journal-title":"Endocrine"},{"key":"9377_CR14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","volume":"8","author":"JD Schilling","year":"2012","unstructured":"Schilling JD, Mann DL (2012) Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin 8:619\u2013631","journal-title":"Heart Fail Clin"},{"key":"9377_CR15","doi-asserted-by":"crossref","first-page":"R1787","DOI":"10.1152\/ajpregu.00059.2007","volume":"293","author":"VA Lacombe","year":"2007","unstructured":"Lacombe VA, Viatchenko-Karpinski S, Terentyev D et al (2007) Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes. Am J Physiol Regul Integr Comp Physiol 293:R1787\u2013R1797","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9377_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1113\/expphysiol.2010.055574","volume":"96","author":"FC Howarth","year":"2011","unstructured":"Howarth FC, Qureshi MA, Hassan Z et al (2011) Changing pattern of gene expression is associated with ventricular myocyte dysfunction and altered mechanisms of Ca2+ signalling in young type 2 Zucker diabetic fatty rat heart. Exp Physiol 96:325\u2013337","journal-title":"Exp Physiol"},{"key":"9377_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yjmcc.2005.03.014","volume":"39","author":"LE Wold","year":"2005","unstructured":"Wold LE, Dutta K, Mason MM et al (2005) Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J Mol Cell Cardiol 39:297\u2013307","journal-title":"J Mol Cell Cardiol"},{"key":"9377_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543\u2013567","journal-title":"Endocr Rev"},{"key":"9377_CR19","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","volume":"116","author":"JM McGavock","year":"2007","unstructured":"McGavock JM, Lingvay I, Zib I et al (2007) Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116:1170\u20131175","journal-title":"Circulation"},{"key":"9377_CR20","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/CIRCULATIONAHA.110.955542","volume":"122","author":"AC Ng","year":"2010","unstructured":"Ng AC, Delgado V, Bertini M et al (2010) Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. Circulation 122:2538\u20132544","journal-title":"Circulation"},{"key":"9377_CR21","doi-asserted-by":"crossref","first-page":"H146","DOI":"10.1152\/ajpheart.00583.2005","volume":"290","author":"JJ Greer","year":"2006","unstructured":"Greer JJ, Ware DP, Lefer DJ (2006) Myocardial infarction and heart failure in the db\/db diabetic mouse. Am J Physiol Heart Circ Physiol 290:H146\u2013H153","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR22","doi-asserted-by":"crossref","first-page":"H256","DOI":"10.1152\/ajpheart.2000.278.1.H256","volume":"278","author":"S Hoshida","year":"2000","unstructured":"Hoshida S, Yamashita N, Otsu K et al (2000) Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 278:H256\u2013H262","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2337\/db06-0739","volume":"56","author":"J Fauconnier","year":"2007","unstructured":"Fauconnier J, Andersson DC, Zhang SJ et al (2007) Effects of palmitate on Ca(2+) handling in adult control and ob\/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 56:1136\u20131142","journal-title":"Diabetes"},{"key":"9377_CR24","first-page":"356","volume":"61","author":"ML Graham","year":"2011","unstructured":"Graham ML, Janecek JL, Kittredge JA et al (2011) The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources. Comp Med 61:356\u2013360","journal-title":"Comp Med"},{"key":"9377_CR25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbrc.2004.04.138","volume":"318","author":"LE Wold","year":"2004","unstructured":"Wold LE, Ren J (2004) Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 MAP kinase-dependent oxidative stress mechanism. Biochem Biophys Res Comm 318:1066\u20131071","journal-title":"Biochem Biophys Res Comm"},{"key":"9377_CR26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0021-9150(99)00265-8","volume":"148","author":"JP Corsetti","year":"2000","unstructured":"Corsetti JP, Sparks JD, Peterson RG et al (2000) Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 148:231\u2013241","journal-title":"Atherosclerosis"},{"key":"9377_CR27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2337\/diab.44.12.1447","volume":"44","author":"Y Tokuyama","year":"1995","unstructured":"Tokuyama Y, Sturis J, DePaoli AM et al (1995) Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447\u20131457","journal-title":"Diabetes"},{"key":"9377_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/bbrc.1996.0691","volume":"222","author":"M Iida","year":"1996","unstructured":"Iida M, Murakami T, Ishida K et al (1996) Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa\/fa) rat. Biochem Biophys Res Commun 222:19\u201326","journal-title":"Biochem Biophys Res Commun"},{"key":"9377_CR29","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","volume":"52","author":"SS Martin","year":"2008","unstructured":"Martin SS, Qasim A, Reilly MP (2008) Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 52:1201\u20131210","journal-title":"J Am Coll Cardiol"},{"key":"9377_CR30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772\u2013783","journal-title":"Nat Rev Immunol"},{"key":"9377_CR31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820","journal-title":"Nature"},{"key":"9377_CR32","first-page":"1","volume":"22","author":"PJ Randle","year":"1966","unstructured":"Randle PJ, Garland PB, Hales CN et al (1966) Interactions of metabolism and the physiological role of insulin. Recent Prog Horm Res 22:1\u201348","journal-title":"Recent Prog Horm Res"},{"key":"9377_CR33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.36.030174.002213","volume":"36","author":"JR Neely","year":"1974","unstructured":"Neely JR, Morgan HE (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36:413\u2013459","journal-title":"Annu Rev Physiol"},{"key":"9377_CR34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0163-7827(02)00065-6","volume":"42","author":"N Sambandam","year":"2003","unstructured":"Sambandam N, Lopaschuk GD (2003) AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42:238\u2013256","journal-title":"Prog Lipid Res"},{"key":"9377_CR35","first-page":"123","volume":"27","author":"JB Chappell","year":"1968","unstructured":"Chappell JB, Robinson BH (1968) Penetration of the mitochondrial membrane by tricarboxylic acid anions. Biochem Soc Symp 27:123\u2013133","journal-title":"Biochem Soc Symp"},{"key":"9377_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","volume":"109","author":"BN Finck","year":"2002","unstructured":"Finck BN, Lehman JJ, Leone TC et al (2002) The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109:121\u2013130","journal-title":"J Clin Invest"},{"key":"9377_CR37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2337\/diab.35.5.593","volume":"35","author":"SW Schaffer","year":"1986","unstructured":"Schaffer SW, Seyed-Mozaffari M, Cutcliff CR et al (1986) Postreceptor myocardial metabolic defect in a rat model of non-insulin-dependent diabetes mellitus. Diabetes 35:593\u2013597","journal-title":"Diabetes"},{"key":"9377_CR38","doi-asserted-by":"crossref","first-page":"H153","DOI":"10.1152\/ajpheart.01142.2008","volume":"297","author":"S Serpillon","year":"2009","unstructured":"Serpillon S, Floyd BC, Gupte RS et al (2009) Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am J Physiol Heart Circ Physiol 297:H153\u2013H162","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.lfs.2006.11.035","volume":"80","author":"SY Li","year":"2007","unstructured":"Li SY, Sigmon VK, Babcock SA et al (2007) Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes. Life Sci 80:1051\u20131056","journal-title":"Life Sci"},{"key":"9377_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3132\/dvdr.2004.001","volume":"1","author":"SF Yan","year":"2004","unstructured":"Yan SF, Ramasamy R, Bucciarelli LG et al (2004) RAGE and its ligands: a lasting memory in diabetic complications? Diab Vasc Dis Res 1:10\u201320","journal-title":"Diab Vasc Dis Res"},{"key":"9377_CR41","doi-asserted-by":"crossref","first-page":"C1370","DOI":"10.1152\/ajpcell.00422.2006","volume":"292","author":"N Fulop","year":"2007","unstructured":"Fulop N, Mason MM, Dutta K et al (2007) Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol 292:C1370\u2013C1378","journal-title":"Am J Physiol Cell Physiol"},{"key":"9377_CR42","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","volume":"96","author":"Y Hu","year":"2005","unstructured":"Hu Y, Belke D, Suarez J et al (2005) Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96:1006\u20131013","journal-title":"Circ Res"},{"key":"9377_CR43","doi-asserted-by":"crossref","first-page":"44230","DOI":"10.1074\/jbc.M303810200","volume":"278","author":"RJ Clark","year":"2003","unstructured":"Clark RJ, McDonough PM, Swanson E et al (2003) Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278:44230\u201344237","journal-title":"J Biol Chem"},{"key":"9377_CR44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1113\/expphysiol.1992.sp003649","volume":"77","author":"MA Cotter","year":"1992","unstructured":"Cotter MA, Cameron NE, Robertson S (1992) Polyol pathway-mediated changes in cardiac muscle contractile properties: studies in streptozotocin-diabetic and galactose-fed rats. Exp Physiol 77:829\u2013838","journal-title":"Exp Physiol"},{"key":"9377_CR45","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpcell.1998.275.1.C75","volume":"275","author":"N Trueblood","year":"1998","unstructured":"Trueblood N, Ramasamy R (1998) Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol 275:H75\u2013H83","journal-title":"Am J Physiol"},{"key":"9377_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1475-2840-9-43","volume":"9","author":"C Ojaimi","year":"2010","unstructured":"Ojaimi C, Kinugawa S, Recchia FA et al (2010) Oxidant-NO dependent gene regulation in dogs with type I diabetes: impact on cardiac function and metabolism. Cardiovasc Diabetol 9:43","journal-title":"Cardiovasc Diabetol"},{"key":"9377_CR47","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","volume":"97","author":"XL Du","year":"2000","unstructured":"Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222\u201312226","journal-title":"Proc Natl Acad Sci USA"},{"key":"9377_CR48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","volume":"404","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787\u2013790","journal-title":"Nature"},{"key":"9377_CR49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","volume":"25","author":"P Pacher","year":"2007","unstructured":"Pacher P, Szabo C (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25:235\u2013260","journal-title":"Cardiovasc Drug Rev"},{"key":"9377_CR50","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","volume":"112","author":"X Du","year":"2003","unstructured":"Du X, Matsumura T, Edelstein D et al (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112:1049\u20131057","journal-title":"J Clin Invest"},{"key":"9377_CR51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.vph.2012.03.005","volume":"57","author":"SW Schaffer","year":"2012","unstructured":"Schaffer SW, Jong CJ, Mozaffari M (2012) Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascul Pharmacol 57:139\u2013149","journal-title":"Vascul Pharmacol"},{"key":"9377_CR52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0003-9861(71)90244-X","volume":"143","author":"O Wieland","year":"1971","unstructured":"Wieland O, Siess E, Schulze-Wethmar FH et al (1971) Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 143:593\u2013601","journal-title":"Arch Biochem Biophys"},{"key":"9377_CR53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0003-9861(78)90068-1","volume":"191","author":"RG Hansford","year":"1978","unstructured":"Hansford RG, Cohen L (1978) Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch Biochem Biophys 191:65\u201381","journal-title":"Arch Biochem Biophys"},{"key":"9377_CR54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1152\/physrev.1990.70.2.391","volume":"70","author":"JG McCormack","year":"1990","unstructured":"McCormack JG, Halestrap AP, Denton RM (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70:391\u2013425","journal-title":"Physiol Rev"},{"key":"9377_CR55","doi-asserted-by":"crossref","first-page":"H270","DOI":"10.1152\/ajpheart.00852.2002","volume":"285","author":"TA Hopkins","year":"2003","unstructured":"Hopkins TA, Sugden MC, Holness MJ et al (2003) Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice. Am J Physiol Heart Circ Physiol 285:H270\u2013H276","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR56","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1074\/jbc.M106054200","volume":"277","author":"FM Campbell","year":"2002","unstructured":"Campbell FM, Kozak R, Wagner A et al (2002) A role for peroxisome proliferator-activated receptor alpha (PPARalpha) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J Biol Chem 277:4098\u20134103","journal-title":"J Biol Chem"},{"key":"9377_CR57","first-page":"H52","volume":"273","author":"JC Chatham","year":"1997","unstructured":"Chatham JC, Forder JR (1997) Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol 273:H52\u2013H58","journal-title":"Am J Physiol"},{"key":"9377_CR58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.108.765750","volume":"2","author":"KA Connelly","year":"2009","unstructured":"Connelly KA, Kelly DJ, Zhang Y et al (2009) Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail 2:129\u2013137","journal-title":"Circ Heart Fail"},{"key":"9377_CR59","doi-asserted-by":"crossref","first-page":"C413","DOI":"10.1152\/ajpcell.00362.2007","volume":"294","author":"C Ricci","year":"2008","unstructured":"Ricci C, Pastukh V, Leonard J et al (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol 294:C413\u2013C422","journal-title":"Am J Physiol Cell Physiol"},{"key":"9377_CR60","doi-asserted-by":"crossref","first-page":"40567","DOI":"10.1074\/jbc.M100052200","volume":"276","author":"JJ Luiken","year":"2001","unstructured":"Luiken JJ, Arumugam Y, Dyck DJ et al (2001) Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276:40567\u201340573","journal-title":"J Biol Chem"},{"key":"9377_CR61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1020539932353","volume":"239","author":"SL Coort","year":"2002","unstructured":"Coort SL, Willems J, Coumans WA et al (2002) Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT\/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem 239:213\u2013219","journal-title":"Mol Cell Biochem"},{"key":"9377_CR62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD et al (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207\u2013258","journal-title":"Physiol Rev"},{"key":"9377_CR63","doi-asserted-by":"crossref","first-page":"E781","DOI":"10.1152\/ajpendo.00573.2003","volume":"287","author":"A Chabowski","year":"2004","unstructured":"Chabowski A, Coort SL, Calles-Escandon J et al (2004) Insulin stimulates fatty acid transport by regulating expression of FAT\/CD36 but not FABPpm. Am J Physiol Endocrinol Metab 287:E781\u2013E789","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9377_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00424-003-1199-4","volume":"448","author":"JJ Luiken","year":"2004","unstructured":"Luiken JJ, Coort SL, Koonen DP et al (2004) Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 448:1\u201315","journal-title":"Pflugers Arch"},{"key":"9377_CR65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbalip.2005.03.005","volume":"1734","author":"AN Carley","year":"2005","unstructured":"Carley AN, Severson DL (2005) Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734:112\u2013126","journal-title":"Biochim Biophys Acta"},{"key":"9377_CR66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","volume":"5","author":"WL Holland","year":"2007","unstructured":"Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167\u2013179","journal-title":"Cell Metab"},{"key":"9377_CR67","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/diab.37.10.1358","volume":"37","author":"B Rodrigues","year":"1988","unstructured":"Rodrigues B, Xiang H, McNeill JH (1988) Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37:1358\u20131364","journal-title":"Diabetes"},{"key":"9377_CR68","doi-asserted-by":"crossref","first-page":"H1196","DOI":"10.1152\/ajpheart.2000.278.4.H1196","volume":"278","author":"J Sakamoto","year":"2000","unstructured":"Sakamoto J, Barr RL, Kavanagh KM et al (2000) Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol Heart Circ Physiol 278:H1196\u2013H1204","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR69","doi-asserted-by":"crossref","first-page":"17513","DOI":"10.1074\/jbc.270.29.17513","volume":"270","author":"N Kudo","year":"1995","unstructured":"Kudo N, Barr AJ, Barr RL et al (1995) High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5\u2032-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270:17513\u201317520","journal-title":"J Biol Chem"},{"key":"9377_CR70","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0026-0495(97)90229-8","volume":"46","author":"J Gamble","year":"1997","unstructured":"Gamble J, Lopaschuk GD (1997) Insulin inhibition of 5\u2032 adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 46:1270\u20131274","journal-title":"Metabolism"},{"key":"9377_CR71","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1152\/ajpendo.2001.280.3.E471","volume":"280","author":"ME Young","year":"2001","unstructured":"Young ME, Goodwin GW, Ying J et al (2001) Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids. Am J Physiol Endocrinol Metab 280:E471\u2013E479","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9377_CR72","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1073\/pnas.0336724100","volume":"100","author":"BN Finck","year":"2003","unstructured":"Finck BN, Han X, Courtois M et al (2003) A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100:1226\u20131231","journal-title":"Proc Natl Acad Sci USA"},{"key":"9377_CR73","doi-asserted-by":"crossref","first-page":"e45541","DOI":"10.1371\/journal.pone.0045541","volume":"7","author":"W Chen","year":"2012","unstructured":"Chen W, Xia Y, Zhao X et al (2012) The critical role of astragalus polysaccharides for the improvement of PPRAalpha-mediated lipotoxicity in diabetic cardiomyopathy. PLoS ONE 7:e45541","journal-title":"PLoS ONE"},{"key":"9377_CR74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cvr\/cvn172","volume":"80","author":"BC Yu","year":"2008","unstructured":"Yu BC, Chang CK, Ou HY et al (2008) Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Cardiovasc Res 80:78\u201387","journal-title":"Cardiovasc Res"},{"key":"9377_CR75","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1116","volume":"10","author":"L Cheng","year":"2004","unstructured":"Cheng L, Ding G, Qin Q et al (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10:1245\u20131250","journal-title":"Nat Med"},{"key":"9377_CR76","first-page":"3930","volume":"117","author":"EM Burkart","year":"2007","unstructured":"Burkart EM, Sambandam N, Han X et al (2007) Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 117:3930\u20133939","journal-title":"J Clin Invest"},{"key":"9377_CR77","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/S0021-9258(18)96494-X","volume":"241","author":"RH Bowman","year":"1966","unstructured":"Bowman RH (1966) Effects of diabetes, fatty acids, and ketone bodies on tricarboxylic acid cycle metabolism in the perfused rat heart. J Biol Chem 241:3041\u20133048","journal-title":"J Biol Chem"},{"key":"9377_CR78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(85)91907-5","volume":"1","author":"H Taegtmeyer","year":"1985","unstructured":"Taegtmeyer H, Passmore JM (1985) Defective energy metabolism of the heart in diabetes. Lancet 1:139\u2013141","journal-title":"Lancet"},{"key":"9377_CR79","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2337\/diab.32.9.781","volume":"32","author":"TH Kuo","year":"1983","unstructured":"Kuo TH, Moore KH, Giacomelli F et al (1983) Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 32:781\u2013787","journal-title":"Diabetes"},{"key":"9377_CR80","first-page":"48","volume":"1","author":"GN Pierce","year":"1985","unstructured":"Pierce GN, Dhalla NS (1985) Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1:48\u201354","journal-title":"Can J Cardiol"},{"key":"9377_CR81","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1253\/jcj.60.673","volume":"60","author":"M Tomita","year":"1996","unstructured":"Tomita M, Mukae S, Geshi E et al (1996) Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart. Jpn Circ J 60:673\u2013682","journal-title":"Jpn Circ J"},{"key":"9377_CR82","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/CIRCULATIONAHA.105.554360","volume":"112","author":"S Boudina","year":"2005","unstructured":"Boudina S, Sena S, O\u2019Neill BT et al (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686\u20132695","journal-title":"Circulation"},{"key":"9377_CR83","doi-asserted-by":"crossref","first-page":"C1561","DOI":"10.1152\/ajpcell.00076.2008","volume":"295","author":"J Suarez","year":"2008","unstructured":"Suarez J, Hu Y, Makino A et al (2008) Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes. Am J Physiol Cell Physiol 295:C1561\u2013C1568","journal-title":"Am J Physiol Cell Physiol"},{"key":"9377_CR84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11010-009-0100-y","volume":"330","author":"M Zungu","year":"2009","unstructured":"Zungu M, Young ME, Stanley WC et al (2009) Chronic treatment with the peroxisome proliferator-activated receptor alpha agonist Wy-14,643 attenuates myocardial respiratory capacity and contractile function. Mol Cell Biochem 330:55\u201362","journal-title":"Mol Cell Biochem"},{"key":"9377_CR85","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/db07-0481","volume":"56","author":"S Boudina","year":"2007","unstructured":"Boudina S, Sena S, Theobald H et al (2007) Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56:2457\u20132466","journal-title":"Diabetes"},{"key":"9377_CR86","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/hrt.2003.020842","volume":"90","author":"H Bibra von","year":"2004","unstructured":"von Bibra H, Hansen A, Dounis V et al (2004) Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 90:1483\u20131484","journal-title":"Heart"},{"key":"9377_CR87","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-2007-973608","volume":"132","author":"H Bibra von","year":"2007","unstructured":"von Bibra H, Siegmund T, Hansen A et al (2007) Augmentation of myocardial function by improved glycemic control in patients with type 2 diabetes mellitus. Dtsch Med Wochenschr 132:729\u2013734","journal-title":"Dtsch Med Wochenschr"},{"key":"9377_CR88","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.107.704080","volume":"117","author":"DK McGuire","year":"2008","unstructured":"McGuire DK, Inzucchi SE (2008) New drugs for the treatment of diabetes mellitus: part I: thiazolidinediones and their evolving cardiovascular implications. Circulation 117:440\u2013449","journal-title":"Circulation"},{"key":"9377_CR89","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2006-1268","volume":"92","author":"AM Sharma","year":"2007","unstructured":"Sharma AM, Staels B (2007) Review: peroxisome proliferator-activated receptor gamma and adipose tissue\u2013understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 92:386\u2013395","journal-title":"J Clin Endocrinol Metab"},{"key":"9377_CR90","doi-asserted-by":"crossref","first-page":"113B","DOI":"10.1016\/j.amjcard.2006.11.013","volume":"99","author":"FA Masoudi","year":"2007","unstructured":"Masoudi FA, Inzucchi SE (2007) Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy. Am J Cardiol 99:113B\u2013132B","journal-title":"Am J Cardiol"},{"key":"9377_CR91","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.0000154542.13412.B1","volume":"111","author":"FA Masoudi","year":"2005","unstructured":"Masoudi FA, Inzucchi SE, Wang Y et al (2005) Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 111:583\u2013590","journal-title":"Circulation"},{"key":"9377_CR92","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","volume":"110","author":"LA Nikolaidis","year":"2004","unstructured":"Nikolaidis LA, Elahi D, Hentosz T et al (2004) Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 110:955\u2013961","journal-title":"Circulation"},{"key":"9377_CR93","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","volume":"12","author":"GG Sokos","year":"2006","unstructured":"Sokos GG, Nikolaidis LA, Mankad S et al (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12:694\u2013699","journal-title":"J Card Fail"},{"key":"9377_CR94","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","volume":"359","author":"JL Chiasson","year":"2002","unstructured":"Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072\u20132077","journal-title":"Lancet"},{"key":"9377_CR95","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2337\/diacare.28.7.1840","volume":"28","author":"M Hanefeld","year":"2005","unstructured":"Hanefeld M, Josse RG, Chiasson JL (2005) Alpha-glucosidase inhibitors for patients with type 2 diabetes: response to van de Laar et al. Diabet Care 28:1840 (author reply 1)","journal-title":"Diabet Care"},{"key":"9377_CR96","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehm361","volume":"28","author":"E Konduracka","year":"2007","unstructured":"Konduracka E, Gackowski A, Rostoff P et al (2007) Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 28:2465\u20132471","journal-title":"Eur Heart J"},{"key":"9377_CR97","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","volume":"146","author":"SJ Haas","year":"2003","unstructured":"Haas SJ, Vos T, Gilbert RE et al (2003) Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 146:848\u2013853","journal-title":"Am Heart J"},{"key":"9377_CR98","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1464-5491.2007.02151.x","volume":"24","author":"V Fonseca","year":"2007","unstructured":"Fonseca V, Bakris GL, Bell DS et al (2007) Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI. Diabet Med 24:759\u2013763","journal-title":"Diabet Med"},{"key":"9377_CR99","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","volume":"51","author":"K Ramasubbu","year":"2008","unstructured":"Ramasubbu K, Estep J, White DL et al (2008) Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 51:415\u2013426","journal-title":"J Am Coll Cardiol"},{"key":"9377_CR100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCRESAHA.109.199810","volume":"105","author":"TO Stolen","year":"2009","unstructured":"Stolen TO, Hoydal MA, Kemi OJ et al (2009) Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res 105:527\u2013536","journal-title":"Circ Res"},{"key":"9377_CR101","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jdiacomp.2009.03.001","volume":"24","author":"FC Howarth","year":"2010","unstructured":"Howarth FC, Almugaddum FA, Qureshi MA et al (2010) The effects of heavy long-term exercise on ventricular myocyte shortening and intracellular Ca2+ in streptozotocin-induced diabetic rat. J Diabet Complicat 24:278\u2013285","journal-title":"J Diabet Complicat"},{"key":"9377_CR102","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","volume":"1771","author":"A Rubenstrunk","year":"2007","unstructured":"Rubenstrunk A, Hanf R, Hum DW et al (2007) Safety issues and prospects for future generations of PPAR modulators. Biochim Biophys Acta 1771:1065\u20131081","journal-title":"Biochim Biophys Acta"},{"key":"9377_CR103","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-199652050-00008","volume":"52","author":"KL Goa","year":"1996","unstructured":"Goa KL, Barradell LB, Plosker GL (1996) Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia. Drugs 52:725\u2013753","journal-title":"Drugs"},{"key":"9377_CR104","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.beem.2007.09.004","volume":"21","author":"B Gross","year":"2007","unstructured":"Gross B, Staels B (2007) PPAR agonists: multimodal drugs for the treatment of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 21:687\u2013710","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9377_CR105","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1152\/ajpendo.00358.2003","volume":"286","author":"AJ Davidoff","year":"2004","unstructured":"Davidoff AJ, Mason MM, Davidson MB et al (2004) Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab 286:E718\u2013E724","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9377_CR106","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00125-006-0230-7","volume":"49","author":"F Dong","year":"2006","unstructured":"Dong F, Fang CX, Yang X et al (2006) Cardiac overexpression of catalase rescues cardiac contractile dysfunction induced by insulin resistance: role of oxidative stress, protein carbonyl formation and insulin sensitivity. Diabetologia 49:1421\u20131433","journal-title":"Diabetologia"},{"key":"9377_CR107","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.freeradbiomed.2005.12.009","volume":"40","author":"LE Wold","year":"2006","unstructured":"Wold LE, Ceylan-Isik AF, Fang CX et al (2006) Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med 40:1419\u20131429","journal-title":"Free Radic Biol Med"},{"key":"9377_CR108","doi-asserted-by":"crossref","first-page":"H912","DOI":"10.1152\/ajpheart.00824.2006","volume":"292","author":"N Yaras","year":"2007","unstructured":"Yaras N, Bilginoglu A, Vassort G et al (2007) Restoration of diabetes-induced abnormal local Ca2+ release in cardiomyocytes by angiotensin II receptor blockade. Am J Physiol Heart Circ Physiol 292:H912\u2013H920","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR109","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","volume":"41","author":"PG Shekelle","year":"2003","unstructured":"Shekelle PG, Rich MW, Morton SC et al (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41:1529\u20131538","journal-title":"J Am Coll Cardiol"},{"key":"9377_CR110","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","volume":"37","author":"JR Sowers","year":"2001","unstructured":"Sowers JR, Epstein M, Frohlich ED (2001) Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37:1053\u20131059","journal-title":"Hypertension"},{"key":"9377_CR111","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cardfail.2010.07.249","volume":"16","author":"S Murarka","year":"2010","unstructured":"Murarka S, Movahed MR (2010) Diabetic cardiomyopathy. J Card Fail 16:971\u2013979","journal-title":"J Card Fail"},{"key":"9377_CR112","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.yjmcc.2004.05.006","volume":"37","author":"AK Zaman","year":"2004","unstructured":"Zaman AK, Fujii S, Goto D et al (2004) Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol 37:525\u2013535","journal-title":"J Mol Cell Cardiol"},{"key":"9377_CR113","first-page":"103","volume":"59","author":"A Orea-Tejeda","year":"2007","unstructured":"Orea-Tejeda A, Colin-Ramirez E, Castillo-Martinez L et al (2007) Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients. Rev Invest Clin 59:103\u2013107","journal-title":"Rev Invest Clin"},{"key":"9377_CR114","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1536\/ihj.34.617","volume":"34","author":"T Shimada","year":"1993","unstructured":"Shimada T (1993) Correlation between metabolic and histopathological changes in the myocardium of the KK mouse. Effect of diltiazem on the diabetic heart. Jpn Heart J 34:617\u2013626","journal-title":"Jpn Heart J"},{"key":"9377_CR115","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2337\/diab.37.7.936","volume":"37","author":"N Afzal","year":"1988","unstructured":"Afzal N, Ganguly PK, Dhalla KS et al (1988) Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37:936\u2013942","journal-title":"Diabetes"},{"key":"9377_CR116","first-page":"E453","volume":"256","author":"N Afzal","year":"1989","unstructured":"Afzal N, Pierce GN, Elimban V et al (1989) Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Am J Physiol 256:E453\u2013E458","journal-title":"Am J Physiol"},{"key":"9377_CR117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00005344-199507000-00002","volume":"26","author":"TS Shah","year":"1995","unstructured":"Shah TS, Satia MC, Gandhi TP et al (1995) Effects of chronic nifedipine treatment on streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol 26:6\u201312","journal-title":"J Cardiovasc Pharmacol"},{"key":"9377_CR118","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/0306-3623(95)00036-4","volume":"26","author":"S Higa","year":"1995","unstructured":"Higa S, Shimabukuro M, Shinzato T et al (1995) Long-term nifedipine treatment reduces calcium overload in isolated reperfused hearts of diabetic rats. Gen Pharmacol 26:1679\u20131686","journal-title":"Gen Pharmacol"},{"key":"9377_CR119","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"A Aneja","year":"2008","unstructured":"Aneja A, Tang WH, Bansilal S et al (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121:748\u2013757","journal-title":"Am J Med"},{"key":"9377_CR120","doi-asserted-by":"crossref","first-page":"R1439","DOI":"10.1152\/ajpregu.00736.2007","volume":"295","author":"J Suarez","year":"2008","unstructured":"Suarez J, Scott B, Dillmann WH (2008) Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol 295:R1439\u2013R1445","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"9377_CR121","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00592-009-0164-x","volume":"47","author":"M Wang","year":"2010","unstructured":"Wang M, Zhang WB, Zhu JH et al (2010) Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats. Acta Diabetol 47:209\u2013218","journal-title":"Acta Diabetol"},{"key":"9377_CR122","doi-asserted-by":"crossref","first-page":"H295","DOI":"10.1152\/ajpcell.1998.274.2.C295","volume":"274","author":"TD Giles","year":"1998","unstructured":"Giles TD, Ouyang J, Kerut EK et al (1998) Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB\/Wor diabetic rat. Am J Physiol 274:H295\u2013H307","journal-title":"Am J Physiol"},{"key":"9377_CR123","first-page":"E798","volume":"277","author":"X Liu","year":"1999","unstructured":"Liu X, Wang J, Takeda N et al (1999) Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am J Physiol 277:E798\u2013E804","journal-title":"Am J Physiol"},{"key":"9377_CR124","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2337\/diabetes.50.8.1918","volume":"50","author":"A Malhotra","year":"2001","unstructured":"Malhotra A, Kang BP, Cheung S et al (2001) Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I. Diabetes 50:1918\u20131926","journal-title":"Diabetes"},{"key":"9377_CR125","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1006\/jmcc.2001.1442","volume":"33","author":"Y Shizukuda","year":"2001","unstructured":"Shizukuda Y, Buttrick PM (2001) Protein kinase C(epsilon) modulates apoptosis induced by beta -adrenergic stimulation in adult rat ventricular myocytes via extracellular signal-regulated kinase (ERK) activity. J Mol Cell Cardiol 33:1791\u20131803","journal-title":"J Mol Cell Cardiol"},{"key":"9377_CR126","doi-asserted-by":"crossref","first-page":"H1965","DOI":"10.1152\/ajpheart.00855.2004","volume":"288","author":"V Pastukh","year":"2005","unstructured":"Pastukh V, Wu S, Ricci C et al (2005) Reversal of hyperglycemic preconditioning by angiotensin II: role of calcium transport. Am J Physiol Heart Circ Physiol 288:H1965\u2013H1975","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9377_CR127","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","volume":"94","author":"H Wakasaki","year":"1997","unstructured":"Wakasaki H, Koya D, Schoen FJ et al (1997) Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci USA 94:9320\u20139325","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-013-9377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-013-9377-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-013-9377-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T13:30:58Z","timestamp":1644413458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-013-9377-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9377"],"URL":"https:\/\/doi.org\/10.1007\/s10741-013-9377-8","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}